DEA proposal sparks considerations about entry to telehealth

“The proof doesn’t appear to be there, and I feel within the rule that the DEA proposed, there wasn’t actually sturdy proof cited, both,” Huskamp stated. 

She and different colleagues are calling for extending the prescribing flexibilities by way of not less than December 2024 to assemble extra knowledge. 

Delays in care 

Critics of the proposed rule fear 30 days wouldn’t be sufficient time for an individual to see a physician in particular person, particularly in the event that they don’t have already got a major care doctor. 

“I’m involved {that a} 30-day deadline to see a supplier in-person would trigger a lapse in remedy for people who’ve obtained preliminary prescriptions and encounter a scenario through which they can’t see a physician inside the one-month deadline,” Rep. Frank Pallone Jr., the highest Democrat on the Home Power and Commerce Committee, wrote in a March letter to Milgram. 

Fourteen different members, led by Rep. Ann McLane Kuster, D-N.H., wrote in a letter to Milgram that “a affected person who begins their 30-day remedy through telemedicine has no assure they may be capable to entry an in-person go to inside one month – particularly in rural and medically underserved areas the place [opioid use disorder]workforce shortages persist.” 

See also  Lawmakers eye alternatives as Philippines base entry expands